title: Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League Expert Committee.
abstract: Surveillance and monitoring of cardiovascular risk factors including raised blood pressure are critical to informing efforts to prevent and control cardiovascular disease. Yet, many countries lack the capacity for adequate national surveillance. Furthermore, hypertension indicators are often reported in different ways, which hampers the ability to compare and assess progress. In order to encourage standardized hypertension surveillance reporting, the World Hypertension League assembled an Expert Committee to develop a standard set of core indicators, definitions, and recommended analyses. The recommended core indicators are: (1) blood pressure distribution, (2) prevalence of hypertension, (3) awareness of the condition, (4) antihypertensive drug treatment, and (5) control of hypertension based on drug therapy. Each of these can be reported overall and by age group and sex, with crude and age-standardized changes tracked over time in order to assess the impact of instituted policies and programs for hypertension prevention and control. An expanded list of indicators can also facilitate tracking of hypertension prevention and control efforts. Widespread adoption of these indicators and analyses could benefit all those conducting and analyzing hypertension surveys and will facilitate hypertension surveillance efforts.
authors.affiliation: Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, ON, Canada.
authors.forename: Marianne E
authors.initials: ME
authors.lastname: Gee
authors.forename: Norm
authors.initials: N
authors.lastname: Campbell
authors.forename: Nizal
authors.initials: N
authors.lastname: Sarrafzadegan
authors.forename: Tazeen
authors.initials: T
authors.lastname: Jafar
authors.forename: Tej K
authors.initials: TK
authors.lastname: Khalsa
authors.forename: Birinder
authors.initials: B
authors.lastname: Mangat
authors.forename: Neil
authors.initials: N
authors.lastname: Poulter
authors.forename: Dorairaj
authors.initials: D
authors.lastname: Prabhakaran
authors.forename: Sandor
authors.initials: S
authors.lastname: Sonkodi
authors.forename: Paul K
authors.initials: PK
authors.lastname: Whelton
authors.forename: Mark
authors.initials: M
authors.lastname: Woodward
authors.forename: Xin-Hua
authors.initials: XH
authors.lastname: Zhang
mesh_terms: D000293:Adolescent; D000328:Adult; D026683:Advisory Committees; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001795:Blood Pressure Determination; D003625:Data Collection / Q000592:standards*; D014943:Global Health; D006287:Health Planning Guidelines; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology*; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods*; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents